RVPH - Reviva Pharmaceuticals FY Non-GAAP EPS of -$1.65 beats by $0.01 April, 15 2024 02:15 PM Reviva Pharmaceuticals Holdings Inc. 2024-04-15 14:15:36 ET More on Reviva Pharmaceuticals Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals Historical earnings data for Reviva Pharmaceuticals Financial information for Reviva Pharmaceuticals For further details see: Reviva Pharmaceuticals FY Non-GAAP EPS of -$1.65 beats by $0.01